Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687).

A new series of pyrazinecarboxamide DGAT1 inhibitors was designed to address the need for a candidate drug with good potency, selectivity, and physical and DMPK properties combined with a low predicted dose in man. Rational design and optimization of this series led to the discovery of compound 30 (AZD7687), which met the project objectives for potency, selectivity, in particular over ACAT1, solubility, and preclinical PK profiles. This compound showed the anticipated excellent pharmacokinetic properties in human volunteers.

[1]  Andrew G. Leach,et al.  Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes. , 2012, Bioorganic & medicinal chemistry letters.

[2]  B. Hubbard,et al.  Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides. , 2012, ACS medicinal chemistry letters.

[3]  M. Pruniaux,et al.  Thiadiazoles as new inhibitors of diacylglycerol acyltransferase type 1. , 2012, Bioorganic & medicinal chemistry letters.

[4]  Steven C. Cullen,et al.  Identification and preliminary characterization of a potent, safe, and orally efficacious inhibitor of acyl-CoA:diacylglycerol acyltransferase 1. , 2012, Journal of medicinal chemistry.

[5]  D. A. Pan,et al.  Design and synthesis of potent carboxylic acid DGAT1 inhibitors with high cell permeability. , 2012, Bioorganic & medicinal chemistry letters.

[6]  M. Munchhof,et al.  Design and synthesis of potent, orally-active DGAT-1 inhibitors containing a dioxino[2,3-d]pyrimidine core. , 2011, Bioorganic & medicinal chemistry letters.

[7]  R. Vishwakarma,et al.  Exploration of pyridine containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors. , 2011, Bioorganic & medicinal chemistry letters.

[8]  Eliot Sugarman,et al.  Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1. , 2011, ACS medicinal chemistry letters.

[9]  C. Rondinone,et al.  Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes. , 2011, Journal of medicinal chemistry.

[10]  Masahiro Tanaka,et al.  Discovery of pyrrolopyridazines as novel DGAT1 inhibitors. , 2010, Bioorganic & medicinal chemistry letters.

[11]  Koki Kato,et al.  Novel acyl coenzyme A: diacylglycerol acyltransferase 1 inhibitors-synthesis and biological activities of N-(substituted heteroaryl)-4-(substituted phenyl)-4-oxobutanamides. , 2010, Chemical & pharmaceutical bulletin.

[12]  T. Turner,et al.  Novel acyl coenzyme A (CoA): diacylglycerol acyltransferase-1 inhibitors: synthesis and biological activities of diacylethylenediamine derivatives. , 2010, Bioorganic & medicinal chemistry.

[13]  M. Waring.  Lipophilicity in drug discovery , 2010, Expert opinion on drug discovery.

[14]  Osamu Okazaki,et al.  A Zone Classification System for Risk Assessment of Idiosyncratic Drug Toxicity Using Daily Dose and Covalent Binding , 2009, Drug Metabolism and Disposition.

[15]  M. Waring.  Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability. , 2009, Bioorganic & medicinal chemistry letters.

[16]  A. Turnbull,et al.  Discovery of a potent, selective, and orally efficacious pyrimidinooxazinyl bicyclooctaneacetic acid diacylglycerol acyltransferase-1 inhibitor. , 2009, Journal of medicinal chemistry.

[17]  A. Souers,et al.  Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor. , 2008, Journal of medicinal chemistry.

[18]  John C Lindon,et al.  Acyl glucuronides: biological activity, chemical reactivity, and chemical synthesis. , 2006, Journal of medicinal chemistry.

[19]  M. Vartanian,et al.  Synthesis of cyclic endiamino peptides. , 2005, Journal of the American Chemical Society.

[20]  K. Janda,et al.  N-h insertion reactions of Boc-amino acid amides: solution- and solid-phase synthesis of pyrazinones and pyrazines. , 2004, Organic letters.

[21]  J. C. Peterson,et al.  Detonation properties of ethyl diazoacetate , 2002 .

[22]  Andrew G. Leach,et al.  Design and synthesis of a novel series of cyclohexyloxy-pyridyl derivatives as inhibitors of diacylglycerol acyl transferase 1 , 2013 .

[23]  R. Coleman.  Diacylglycerol acyltransferase and monoacylglycerol acyltransferase from liver and intestine. , 1992, Methods in enzymology.